Jason Kelce
Center
- 2019 Salary Cap Charge: $2,444,000
- % of 2019 Team Cap: 1.24%
- 2019 Cash Payout: $8,500,000
- % of 2019 Team Cash Spending: 4.10%
- 2019 Cash to Cap Ratio: 3.48
- Total Contract Value: $24,500,000
- Annual Contract Value: $8,166,667
- Position Ranking: 17/91 at C
- Fully Guaranteed Money: $10,500,000
- Age: 32
- Height: 6' 3"
- Weight: 295
- College: Cincinnati
- Accrued Seasons: 9
- Entry: 2011 Draft, Round 6, #191 overall (Eagles)
- Year Signed: 2019 (Other)
- Free Agency: 2022 (UFA)
- 2019 OTC Valuation: $6,061,000
Contract Notes
Jason Kelce signed a 3 year contract with the Eagles on March 5, 2019. Kelce had two years remaining under contract but based on the contract structure we are valuing this as an entirely new contract. The total value of the contract is $24.5 million with $19 million guaranteed for injury and $10.5 million fully guaranteed at signing. The full guarantee consists of a $7.57 million signing bonus, $2 million 2020 roster bonus, and Kelce's 2019 salary. The Eagles can exercise a $7.5 million option for the 2021 league year in the early part of the 2020 league year. If the Eagles fail to exercise the option Kelce's salary will escalate to match the option figure and it will be guaranteed. The 2022 through 2024 seasons are void years that are included for the purposes of salary cap proration. The new contract reduced Kelce's 2019 salary cap charge by $4.056 million.Current Contract
(📝: indicates contract trigger occuring during that year)| Year | Age | Base Salary | Prorated Bonus | Roster Bonus | Guaranteed Salary | Cap Number | Cap % | Dead Money & Cap Savings | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019 | 32 | $930,000 | $1,514,000 | $0 | $930,000 | $2,444,000 | 1.3% | |||||
| 2020
March 18: 5th day of league year roster bonus due March 22: Base salary becomes fully guaranteed March 27: Deadline to exercise 2021 option year
| 33 | $1,500,000 | $2,914,000 | $2,000,000 | $2,000,000 | $6,414,000 | 3.2% | |||||
| 2021 | 34 | $5,500,000 | $2,914,000 | $0 | $0 | $8,414,000 | -- | |||||
| 2022
February 16: 2022, 2023, and 2024 dummy years void
| 35 | $0 | $2,914,000 | $0 | $0 | $2,914,000 | -- | |||||
| 2023 | 36 | $0 | $2,914,000 | $0 | $0 | $2,914,000 | -- | |||||
| 2024 | 37 | $0 | $1,400,000 | $0 | $0 | $1,400,000 | -- | |||||
| Total | $7,930,000 | $14,570,000 | $2,000,000 | $2,930,000 | $24,500,000 | |||||||
Career Earnings: $42,590,432
Career APY: $4,732,270
Potential Earnings: $51,590,432
Total Guarantees: $20,995,432
Largest Cash Payment: $10,500,000 (2020)
Largest Cap Hit: $8,414,000 (2021)
Contract History
| Team | Contract Type | Status | Year Signed | Yrs | Total | APY | Guarantees | Amount Earned | % Earned | Effective APY |
|---|---|---|---|---|---|---|---|---|---|---|
| Eagles | Drafted | Renegotiated | 2011 | 4 | $2,137,432 | $534,358 | $97,432 | $1,492,432 | 69.8% | $497,477 |
| Eagles | Extension | Renegotiated | 2014 | 6 | $37,667,000 | $6,277,833 | $10,398,000 | $25,598,000 | 68.0% | $5,119,600 |
| Eagles | Other | Active | 2019 | 3 | $24,500,000 | $8,166,667 | $10,500,000 | $15,500,000 | 63.3% | $15,500,000 |
Earnings By Team
| Team | Yrs | Salary | APY | Paid on Cap | % Paid on Cap | Paid as Dead Money | % Paid as Dead Money |
|---|---|---|---|---|---|---|---|
| Eagles | 9 | $42,590,432 | $4,732,270 | $29,534,432 | 0.0% | $0 | 0.0% |
Salary Cap History
| Year | Team | Base Salary | Prorated Bonus | Roster Bonus | Guaranteed Salary | Cap Number | Cap % | Cash Paid | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2011 | Eagles | $375,000 | $24,358 | $0 | $0 | $399,358 | 0.3% | $472,432 | ||
| 2012 | Eagles | $465,000 | $24,358 | $0 | $0 | $489,358 | 0.4% | $465,000 | ||
| 2013 | Eagles | $555,000 | $24,358 | $0 | $0 | $579,358 | 0.5% | $555,000 | ||
| 2014 | Eagles | $1,398,000 | $1,224,358 | $0 | $1,398,000 | $2,622,358 | 2.0% | $7,398,000 | ||
| 2015 | Eagles | $3,200,000 | $1,200,000 | $0 | $3,000,000 | $4,400,000 | 3.1% | $3,200,000 | ||
| 2016 | Eagles | $4,000,000 | $1,200,000 | $0 | $2,602,000 | $5,200,000 | 3.3% | $4,000,000 | ||
| 2017 | Eagles | $5,000,000 | $1,200,000 | $0 | $0 | $6,200,000 | 3.7% | $5,000,000 | ||
| 2018 | Eagles | $6,000,000 | $1,200,000 | $0 | $0 | $7,200,000 | 4.1% | $6,000,000 | ||
| 2019 | Eagles | $930,000 | $1,514,000 | $0 | $930,000 | $2,444,000 | 1.3% | $8,500,000 | ||
| 2020 | Eagles | $1,500,000 | $2,914,000 | $2,000,000 | $2,000,000 | $6,414,000 | 3.2% | $10,500,000 | ||
| 2021 | Eagles | $5,500,000 | $2,914,000 | $0 | $0 | $8,414,000 | -- | $5,500,000 | ||
| 2022 | Eagles | $0 | $2,914,000 | $0 | $0 | $2,914,000 | -- | $0 | ||
| 2023 | Eagles | $0 | $2,914,000 | $0 | $0 | $2,914,000 | -- | $0 | ||
| 2024 | Eagles | $0 | $1,400,000 | $0 | $0 | $1,400,000 | -- | $0 | ||
| Total | $28,923,000 | $20,667,432 | $2,000,000 | $9,930,000 | $51,590,432 | $51,590,432 | ||||
Statistics
| Year | Games Played | Games Missed | Snaps | ||
|---|---|---|---|---|---|
| Injured | Healthy | Offense | Special | ||
| 2011 | -- | -- | 99.4% | 0.0% | |
| 2012 | 2 | -- | -- | 12.1% | 1.1% |
| 2013 | 16 | 0 | 0 | 99.3% | 0.0% |
| 2014 | 12 | 4 | 0 | 70.3% | 1.2% |
| 2015 | 16 | 0 | 0 | 100.0% | 0.0% |
| 2016 | 16 | 0 | 0 | 100.0% | 1.8% |
| 2017 | 16 | 0 | 0 | 95.4% | 0.0% |
| 2018 | 16 | 0 | 0 | 95.0% | 0.0% |
| 2019 | 16 | 0 | 0 | 100.0% | 0.2% |
Valuation Diamond
The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.
| OTC Valuation | APY | |
|---|---|---|
| Regular | $6,058,000 | $8,166,667 |
| Injury Adjusted | $6,058,000 | $8,166,667 |
test
Weekly Valuation Trends
The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.
To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.